Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05082415 |
|---|---|
| Brief Title: | Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study) |
| First Submitted : | October 5, 2021 |
| First Submitted that Met QC Criteria : | October 5, 2021 |
| First Posted : | October 19, 2021 |
| Last Update Submitted that Met QC Criteria : | October 19, 2021 |
| Last Update Posted : | October 27, 2021 |